TIDMGDR

RNS Number : 2372T

Genedrive PLC

11 October 2017

RNS

For release: 11 October 2017

genedrive plc ("genedrive" or the "Company")

Notice of Preliminary Results

genedrive plc (LSE: GDR), the molecular diagnostics company, will be announcing its preliminary results for the twelve months ending 30 June 2017 on Tuesday 17 October, 2017.

David Budd, Chief Executive Officer, and Matthew Fowler, Chief Financial Officer, will host a presentation and simultaneous live conference call for analysts, followed by a Q&A session, at 11:00am on the day of the results. The presentation will be held at 85 Gresham Street, London, EC2R 7HE.

- Ends -

For further details please contact:

genedrive plc

David Budd: CEO +44 (0)161 989 0245

Matthew Fowler: Finance Director

Peel Hunt LLP

James Steel

+44 (0)207 418 8900

Oliver Jackson

Consilium Strategic Communications

Chris Gardner +44 (0)203 709 5700

Matthew Neal

Laura Thornton

genedrive@consilium-comms.com

Notes to Editors

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Further details can be found at: www.genedriveplc.com and www.genedrive.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOROKKDNPBDDFKD

(END) Dow Jones Newswires

October 11, 2017 02:00 ET (06:00 GMT)

Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Genedrive Charts.
Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Genedrive Charts.